Á¦22Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ : 2023-09-22
±³À°ÀÏÀÚ : 2023-09-22
±³À°Àå¼Ò : The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ
±³À°ÁÖÁ¦ : Á¦22Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ
´ã´çÀÚ : Á¤ÇýÀ±
¿¬¶ôó : 02-2626-1099
À̸ÞÀÏ : office@korvac.org
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú, ¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ȸ¿ø1)Àü¹®ÀÇ,¹Ú»ç±Þ ÀÌ»ó ¼±ÀÓ ¹× Ã¥ÀÓ¿¬±¸ÀÚ: »çÀüµî·Ï5¸¸¿ø.Ãß°¡µî·Ï7¸¸¿ø 2)Àü°øÀÇ,´ëÇлý ¹× ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø: »çÀüµî·Ï3¸¸¿ø/Ãß°¡µî·Ï5¸¸¿øºñȸ¿ø »çÀüµî·Ï 8¸¸¿ø/Ãß°¡µî·Ï10¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 09:00~09:30 Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2 ÀÌÈï±Ô(KAIST)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 09:30~10:00 A novel synthetic dsRNA-based TLR3 agonist as an effective vaccine adjuvant ÇѽÂÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 10:00~10:30 Mechanisms and immunoenhancing effects of RNA-based adjuvants on vaccines ³²Àçȯ(°¡Å縯´ë )
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 10:30~11:00 Targeting immunosenescence: the development of vaccine adjuvant Á¶°æ¾Æ(Àü³²ÀÇ´ë)
ÈÞ½Ä 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 11:00~11:15 Coffee break ()
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 11:15~12:00 Perspectives on Immunization Polices of Korea ÃÖÀºÈ(¼¿ïÀÇ´ë)
±âŸ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 12:00~12:20 ÃÑȸ ()
½Ä»ç 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 12:20~13:20 Satellite symposium(Sequirus) ()
ÈÞ½Ä 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 13:20~13:30 Coffee break ()
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 13:30~14:00 Post-emergency COVID-19 vaccine strategy ÃÖ¿ø¼®(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 14:00~14:30 Outbreak of monkeypox and national vaccine plan ±Ç±Ù¿ë(Áúº´°ü¸®Ã» ¿¹¹æÁ¢Á¾°ü¸®°ú)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 14:30~15:00 Current status of vaccine development and clinical trials for emerging infectious diseases ³ëÁöÀ±(°í·ÁÀÇ´ë)
ÈÞ½Ä 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 15:00~15:15 Coffee break ()
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 15:15~16:30 Oral presentation _Papers on vacccine research and development ÃÖÁ¤Çö/¼Ûâ¼±(°¡Å縯ÀÇ´ë/°Ç±¹¼öÀÇ´ë)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 16:30~17:00 Updates of respiratory syncytial virus prevention: vaccines and monoclonal antibodies ÃÖ¼öÇÑ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 17:00~17:30 Strategic vaccine challenges in the global control of high pathogenicity avian influenza ¼Ûâ¼± (°Ç±¹¼öÀÇ´ë)
±³À°½Ã°£ 09¿ù 22ÀÏ The-K È£ÅÚ ¼¿ï °¡¾ß±ÝȦ 17:30~18:00 From doubt to confidence: navigating vaccine heistancy ÀÌÁø(°¡Å縯ÀÇ´ë)